Positive market breadth

Image
Capital Market
Last Updated : Apr 12 2018 | 10:50 AM IST

Key benchmark indices were trading with small gains in morning trade as buying in IT stocks was offset by selling pressure in pharmaceutical shares. At 10:30 IST, the barometer index, the S&P BSE Sensex, was up 54.58 points or 0.16% at 33,995.02. The Nifty 50 index was up 3.80 points or 0.04% at 10,420.95. The Sensex pared gains after briefly crossing the 34,000 mark.

The Sensex rose 91.74 points, or 0.27% at the day's high of 34,032.18 in morning trade, its highest intraday level since 13 March 2018. The index fell 15.56 points, or 0.05% at the day's low of 33,924.88 in early trade. The Nifty rose 13.10 points, or 0.13% at the day's high of 10,430.25 in morning trade, its highest intraday level since 13 March 2018. The index fell 21.90 points, or 0.21% at the day's low of 10,395.25 in early trade.

Among secondary barometers, the BSE Mid-Cap index was up 0.08%, underperforming the Sensex. The BSE Small-Cap index was up 0.17%, outperforming the Sensex.

The market breadth, indicating the overall health of the market, turned positive from negative. On BSE, 1081 shares rose and 984 shares fell. A total of 87 shares were unchanged.

IT shares were in demand. TCS (up 2.63%), Hexaware Technologies (up 2.29%), HCL Technologies (up 2.26%), Tech Mahindra (up 1.76%), Persistent Systems (up 1.55%), MindTree (up 1.53%), Oracle Financial Services Software (up 1.43%), Wipro (up 1.10%) and MphasiS (up 0.74%), edged higher.

IT major Infosys was up 2.22%. Infosys announces its Q4 results on Friday, 13 April 2018.

Most pharmaceutical shares declined. Dr Reddy's Laboratories (down 1.91%), Sun Pharmaceutical Industries (down 1.12%), Lupin (down 1.11%), Aurobindo Pharma (down 1.1%), Wockhardt (down 0.99%), Alkem Laboratories (down 0.69%), Cipla (down 0.46%), GlaxoSmithKline Pharmaceuticals (down 0.44%), Strides Shasun (down 0.44%), Glenmark Pharmaceuticals (down 0.36%) and Piramal Enterprises (down 0.1%), edged lower. Divi's Laboratories (up 0.6%), Cadila Healthcare (up 0.67%) and IPCA Laboratories (up 2.29%), edged higher.

Overseas, Asian shares declined after Syria tensions and hawkish statements from the US Federal Reserve dented investors' sentiment. US stocks declined on Wednesday, as worries about geopolitical developments deflated the buying mood on Wall Street. An early morning tweet by President Donald Trump implied the possibility of a military strike in Syria and set the downbeat tone for the session.

Trump's tweet that Russia should "get ready" for a potential strike on Syria came after a likely chemical weapons attack over the weekend on a rebel-held town in the eastern Ghouta region of Syria. The newfound focus on geopolitics took the focus off a trade spat between the US and China.

Investors also digested the release of minutes from the Federal Open Market Committee's (FOMC) March meeting, which reflected that all policymakers expected the US economy to continue growing and for inflation to rise. Those views strengthened the belief that more interest rate hikes lay ahead.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 12 2018 | 10:35 AM IST

Next Story